A detailed history of Cromwell Holdings LLC transactions in Incyte Corp stock. As of the latest transaction made, Cromwell Holdings LLC holds 516 shares of INCY stock, worth $43,720. This represents 0.02% of its overall portfolio holdings.

Number of Shares
516
Previous 575 10.26%
Holding current value
$43,720
Previous $34,000 2.94%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025

SELL
$55.17 - $71.22 $3,255 - $4,201
-59 Reduced 10.26%
516 $35,000
Q1 2025

Apr 30, 2025

BUY
$60.0 - $75.26 $720 - $903
12 Added 2.13%
575 $34,000
Q3 2024

Oct 23, 2024

BUY
$57.33 - $68.61 $16,224 - $19,416
283 Added 101.07%
563 $37,000
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $14,330 - $17,850
280 New
280 $16,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cromwell Holdings LLC Portfolio

Follow Cromwell Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cromwell Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cromwell Holdings LLC with notifications on news.